Bulltick Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bulltick Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,026	Closed	-$255K	–	129
2022 Q4	$255K	Buy	9,026 +1,310	+17%	+$41.6K	0.07%	112
2022 Q3	$254K	Hold	7,716	–	–	0.08%	103
2022 Q2	$243K	Hold	7,716	–	–	0.06%	112
2022 Q1	$354K	Sell	7,716 -4,550	-37%	-$217K	0.08%	105
2021 Q4	$751K	Buy	12,266 +8,500	+226%	+$588K	0.15%	66
2021 Q3	$281K	Sell	3,766 -250	-6%	-$21K	0.06%	109
2021 Q2	$371K	Hold	4,016	–	–	0.09%	83
2021 Q1	$356K	Buy	4,016 +516	+15%	+$51.2K	0.1%	72
2020 Q4	$326K	Buy	+3,500	New	+$279K	0.1%	67

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Bulltick Wealth Management's ARKG Position: Q1 2023 in Review

Bulltick Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 9,026 shares — an estimated $255K sold.

Bulltick Wealth Management first reported a position in ARKG in Q4 2020 and held it in 9 quarters. The position peaked at $751K in Q4 2021. 297 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

Bulltick Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
Bulltick Wealth Management sold 9,026 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $255K.
Bulltick Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 9 quarters.
Bulltick Wealth Management's ARK Genomic Revolution ETF position peaked at $751K in Q4 2021.
297 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Bulltick Wealth Management's 13F filing for Q1 2023, filed 25 Apr 2024.